It was demonstrated that IFN produced from Omicron-infected cells can inhibit infection by Influenza A virus67, so it is plausible that the IFN response elicited by Omicron infection may render nasal epithelia resistant to infection by previous SARS-CoV-2 variants of concern. This evidence concerns the gene IFNA1 and infection.